Therapeutic effects of psyllium in type 2 diabetic patients
- 1 September 2002
- journal article
- Published by Springer Nature in European Journal of Clinical Nutrition
- Vol. 56 (9) , 830-842
- https://doi.org/10.1038/sj.ejcn.1601398
Abstract
The aim of this study was to evaluate the effects of psyllium in type 2 diabetic patients. The study included three phases: phase 1 (1 week), phase 2 (treatment, 14 g fibre/day, 6 weeks) and phase 3 (4 weeks). At the end of each phase a clinical evaluation was performed after the ingestion of a test breakfast of 1824.2 kJ (436 kcal). Measurements included concentrations of blood glucose, insulin, fructosamine, GHbA(1c), C-peptide and 24 h urinary glucose excretion. In addition, uric acid, cholesterol and several mineral and vitamin concentrations were also evaluated. The study was performed at the Department of Pharmacology, Toxicology and Nursing at the University of León (Spain). Twenty type 2 diabetic patients (12 men and 8 women) participated in the study with a mean age of 67.4 y for men and 66 y for women. The mean body mass index of men was 28.2 kg/m(2) and that of women 25.9 kg/m(2). Glucose absorption decreased significantly in the presence of psyllium (12.2%); this reduction is not associated with an important change in insulin levels (5%). GHbA(1c), C-peptide and 24 h urinary glucose excretion decreased (3.8, 14.9 and 22.5%, respectively) during the treatment with fibre (no significant differences) as well as fructosamine (10.9%, significant differences). Psyllium also reduced total and LDL cholesterol (7.7 and 9.2%, respectively, significant differences), and uric acid (10%, significant difference). Minerals and vitamins did not show important changes, except sodium that increased significantly after psyllium administration. The results obtained indicate a beneficial therapeutic effect of psyllium (Plantaben) in the metabolic control of type 2 diabetics as well as in lowering the risk of coronary heart disease. We also conclude that consumption of this fibre does not adversely affect either mineral or vitamin A and E concentrations. Finally, for a greater effectiveness, psyllium treatment should be individually evaluated.Keywords
This publication has 48 references indexed in Scilit:
- Effects of ispaghula husk and guar gum on postprandial glucose and insulin concentrations in healthy subjectsEuropean Journal of Clinical Nutrition, 2001
- Blood glucose, plasma insulin and sensory responses to guar-containing wheat breads: effects of molecular weight and particle size of guar gumBritish Journal of Nutrition, 1991
- Effect of method of administration of psyllium on glycemic response and carbohydrate digestibility.Journal of the American College of Nutrition, 1991
- Effect of Guar Gum on Mineral Balances in NIDDM AdultsDiabetes Care, 1989
- No Glycemic Benefit From Guar Administration in NIDDMDiabetes Care, 1987
- Relationship between changes in GIP concentrations and changes in insulin and C-peptide concentrations after guar gum therapyScandinavian Journal of Clinical and Laboratory Investigation, 1986
- Effect of Pectin on Gastric Emptying and Gut Hormone Release in the Dumping SyndromeScandinavian Journal of Gastroenterology, 1983
- Diet and the Diabetic PatientDiabetes Care, 1983
- Effect of a modified guar gum preparation on glucose and lipid levels in diabetics and healthy volunteersAtherosclerosis, 1982
- Human C-peptide immunoreactivity (CPR) in blood and urine ? Evaluation of a radioimmunoassay method and its clinical applicationsDiabetologia, 1976